Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL533164 | 0.88 | PTGES2 (0.39) | KMT2APOLB | |
| SCHEMBL533170 | 0.88 | S100A9 (0.43) | — | |
| SCHEMBL532776 | 0.82 | FFAR4 (0.54) | ALDH1A1TSHRKMT2APOLB | |
| SCHEMBL3975199 | 0.81 | ALDH1A1 (0.40) | ALDH1A1KDM4EKMT2AMAPK1PTK2B | |
| SCHEMBL532041 | 0.80 | ALDH1A1 (0.42) | ALDH1A1HPGDKDM4ETSHRKMT2A | |
| SCHEMBL532980 | 0.79 | JAK2 (0.48) | ALDH1A1HPGDKDM4ETSHRKMT2A | |
| SCHEMBL534077 | 0.78 | TSHR (0.47) | ALDH1A1TSHRKMT2AMAPK1POLB | |
| SCHEMBL533006 | 0.77 | HTR6 (0.43) | ALDH1A1KDM4EKMT2APOLB | |
| SCHEMBL533083 | 0.76 | EDNRA (0.46) | ALDH1A1POLB | |
| SCHEMBL532979 | 0.76 | ALDH1A1 (0.45) | ALDH1A1KDM4ETSHRKMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2415760-A2 | CCR-9 antagonists | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2012-02-08 | — | — | EP | disclosed |
| US-7319111-B2 | Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2008-01-15 | — | — | US | disclosed |
| US-7319111-B2 | Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2008-01-15 | — | — | US | disclosed |
| US-7319111-B2 | Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2008-01-15 | — | — | US | disclosed |